Elevation Wealth Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.12K Buy
16
+7
+78% +$1.45K ﹤0.01% 1118
2026
Q1
$2.02K Buy
+9
New +$2.24K ﹤0.01% 908
2025
Q4
Sell
-16
Closed -$4.38K 1013
2025
Q3
$4.38K Buy
+16
New +$4.37K ﹤0.01% 504

Other funds holding RMD

Elevation Wealth Partners's RMD Position: Q2 2026 in Review

Elevation Wealth Partners increased its ResMed (RMD) stake by 78% in Q2 2026, buying an estimated $1.45K and bringing the position to 16 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1118.

Elevation Wealth Partners first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.38K in Q3 2025. 265 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Elevation Wealth Partners held 16 shares of ResMed worth $3.12K as of Q2 2026.
  • Elevation Wealth Partners bought 7 ResMed shares in Q2 2026, an estimated $1.45K.
  • ResMed made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #1118 holding.
  • Elevation Wealth Partners first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • Elevation Wealth Partners's ResMed position peaked at $4.38K in Q3 2025.
  • 265 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.